1. Home
  2. AGNT vs FLGT Comparison

AGNT vs FLGT Comparison

Compare AGNT & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGNT Inc. Common Stock

AGNT

AGNT Inc. Common Stock

SELL

Current Price

$2.67

Market Cap

468.6M

Sector

Finance

ML Signal

SELL

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

SELL

Current Price

$24.19

Market Cap

511.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AGNT
FLGT
Founded
2008
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
468.6M
511.0M
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
AGNT
FLGT
Price
$2.67
$24.19
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $5.75
N/A
AVG Volume (30 Days)
★ 1.6M
318.7K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 7.07%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $500,147,681.00
$18,730,000.00
Revenue This Year
$3.76
$3.85
Revenue Next Year
$7.08
$9.64
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 220.39
N/A
52 Week Low
$2.67
$13.46
52 Week High
$5.79
$31.04

Technical Indicators

Market Signals
Indicator
AGNT
FLGT
Relative Strength Index (RSI) 33.49 58.29
Support Level N/A $18.82
Resistance Level $4.20 $24.91
Average True Range (ATR) 0.29 1.42
MACD -0.11 0.31
Stochastic Oscillator 0.59 61.43

Price Performance

Historical Comparison
AGNT
FLGT

About AGNT AGNT Inc. Common Stock

AGNT Inc is a multi-model real estate platform, with brands including eXp Realty, eXp Commercial, NextHome, FrameVR.io, and SUCCESS Enterprises. The group prioritizes transparency, innovation, and long-term value for agents, franchise owners, staff, and shareholders.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Share on Social Networks: